| Lauren Jean Welton, PA-C | |
|
100 Hitchcock Way, D-h Manchester, General Surgery, Manchester, NH 03104-4125 | |
| (603) 695-2840 | |
| Not Available |
| Full Name | Lauren Jean Welton |
|---|---|
| Gender | Female |
| Speciality | Physician Assistant |
| Experience | 10 Years |
| Location | 100 Hitchcock Way, Manchester, New Hampshire |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003228479 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363AS0400X | Physician Assistant - Surgical | 1041 (New Hampshire) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Elliot Hospital | Manchester, NH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Dartmouth-hitchcock Clinic | 4183537509 | 1139 |
| Elliot Professional Services | 6103727920 | 304 |
News Archive
Researchers from Aston University and Birmingham Children's Hospital have developed a new medication regimen that could successfully treat a bacterial infection that could prove fatal to patients with cystic fibrosis or bronchiectasis. The results of the new study were published in the latest issue of the journal Scientific Reports.
The call for human rights as a fundamental component of efforts to prevent new infections and provide treatment for people living with HIV pervaded the XVIII International AIDS Conference today as delegates and local residents prepared for the HIV and Human Rights March through the streets of Vienna this evening. Conference participants are giving voice to the conference theme of Rights Here, Right Now through a number of plenary presentations, sessions, and Global Village and Youth Programme activities.
Tarsa Therapeutics, Inc. today announced completion of its global Phase III ORACAL trial testing the company's once-daily oral recombinant calcitonin for the treatment of postmenopausal osteoporosis. Results from the ORACAL trial are expected in early spring. In addition, Tarsa announced initiation of a new Phase II study of its oral calcitonin for the prevention of postmenopausal osteoporosis.
Immunotherapy that involves treating cancer with the body's own immune cells, or those of a matched donor, shows promise in clinical trials for some patients, but not all.
Chronic, excessive alcohol consumption is a major risk factor for developing chronic pancreatitis (pancreatic inflammation).
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Lauren Jean Welton, PA-C 100 Hitchcock Way, D-h Manchester, General Surgery, Manchester, NH 03104-4125 Ph: (603) 695-2840 | Lauren Jean Welton, PA-C 100 Hitchcock Way, D-h Manchester, General Surgery, Manchester, NH 03104-4125 Ph: (603) 695-2840 |
News Archive
Researchers from Aston University and Birmingham Children's Hospital have developed a new medication regimen that could successfully treat a bacterial infection that could prove fatal to patients with cystic fibrosis or bronchiectasis. The results of the new study were published in the latest issue of the journal Scientific Reports.
The call for human rights as a fundamental component of efforts to prevent new infections and provide treatment for people living with HIV pervaded the XVIII International AIDS Conference today as delegates and local residents prepared for the HIV and Human Rights March through the streets of Vienna this evening. Conference participants are giving voice to the conference theme of Rights Here, Right Now through a number of plenary presentations, sessions, and Global Village and Youth Programme activities.
Tarsa Therapeutics, Inc. today announced completion of its global Phase III ORACAL trial testing the company's once-daily oral recombinant calcitonin for the treatment of postmenopausal osteoporosis. Results from the ORACAL trial are expected in early spring. In addition, Tarsa announced initiation of a new Phase II study of its oral calcitonin for the prevention of postmenopausal osteoporosis.
Immunotherapy that involves treating cancer with the body's own immune cells, or those of a matched donor, shows promise in clinical trials for some patients, but not all.
Chronic, excessive alcohol consumption is a major risk factor for developing chronic pancreatitis (pancreatic inflammation).
› Verified 3 days ago
Justina Jane Volodzko, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 1 Elliot Way, Manchester, NH 03103 Phone: 603-669-5300 | |
Grace Marie Martel, Physician Assistant Medicare: Medicare Enrolled Practice Location: 168 Poplar St, Manchester, NH 03104 Phone: 603-913-5588 | |
Betsy Garnick, PA Physician Assistant Medicare: Medicare Enrolled Practice Location: 1260 Elm St, Manchester, NH 03101 Phone: 603-314-1701 | |
Jill Ryan, PA Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 100 Hitchcock Way, Manchester, NH 03104 Phone: 603-695-2500 | |
Mr. Thomas Kysor, Physician Assistant Medicare: Medicare Enrolled Practice Location: 1260 Elm St, Manchester, NH 03101 Phone: 603-801-1412 | |
Jessica M Montemayor, PA Physician Assistant Medicare: Medicare Enrolled Practice Location: 184 Tarrytown Rd, Manchester, NH 03103 Phone: 603-626-9500 Fax: 603-626-0899 |